Yueh-Lun Lee Selected Research

2- dimethylamino- N- (1- (4- methoxybenzenesulfonyl)- 2,3- dihydro- 1H- indol- 7- yl)acetamide

1/2017	Correction: MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells.
5/2016	MPT0B169, a novel tubulin inhibitor, induces apoptosis in taxol-resistant acute myeloid leukemia cells through mitochondrial dysfunction and Mcl-1 downregulation.
1/2016	MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yueh-Lun Lee Research Topics

Disease

20	Inflammation (Inflammations) 03/2022 - 07/2002
19	Asthma (Bronchial Asthma) 05/2022 - 09/2003
15	Respiratory Hypersensitivity 05/2022 - 07/2004
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 05/2010
4	Eosinophilia 09/2013 - 07/2002
3	Emphysema 10/2022 - 01/2021
3	Neoplasms (Cancer) 06/2022 - 03/2010
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2021
3	Infections 12/2017 - 02/2010
2	Pneumonia (Pneumonitis) 05/2022 - 12/2020
2	Parasitic Diseases (Parasitic Disease) 02/2019 - 09/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2016 - 05/2010
2	Chronic Disease (Chronic Diseases) 03/2010 - 01/2010
1	Lung Neoplasms (Lung Cancer) 06/2022
1	Neoplasm Metastasis (Metastasis) 06/2022
1	Human Influenza (Influenza) 01/2022
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Pleurisy (Pleuritis) 01/2022
1	Pulmonary Tuberculosis 01/2022
1	Apnea 10/2021
1	Lung Injury 12/2020
1	Adenoviridae Infections (Adenovirus Infections) 01/2019
1	Neuroinflammatory Diseases 01/2018
1	Wounds and Injuries (Trauma) 12/2017
1	Snake Bites (Snake Bite) 10/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2016
1	Airway Remodeling 01/2015
1	Leukemia 01/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2011

Drug/Important Bio-Agent (IBA)

14	OvalbuminIBA 05/2022 - 05/2006
14	CytokinesIBA 05/2022 - 07/2004
12	Immunoglobulin E (IgE)IBA 05/2022 - 09/2003
7	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 01/2013
6	Anti-Allergic Agents (Antiallergic Agents)IBA 03/2022 - 01/2015
6	Particulate MatterIBA 01/2022 - 09/2020
5	Interleukin-13IBA 05/2022 - 01/2013
5	Interleukin-5 (Interleukin 5)IBA 05/2022 - 01/2013
5	AllergensIBA 03/2022 - 05/2006
5	AntigensIBA 12/2017 - 07/2004
4	Interleukin-10 (Interleukin 10)IBA 05/2022 - 05/2006
3	Interleukin-4 (Interleukin 4)IBA 05/2022 - 05/2006
3	2- dimethylamino- N- (1- (4- methoxybenzenesulfonyl)- 2,3- dihydro- 1H- indol- 7- yl)acetamideIBA 01/2017 - 01/2016
3	Therapeutic UsesIBA 02/2015 - 05/2006
3	Interleukin-12 (IL 12)IBA 01/2010 - 07/2002
2	ChemokinesIBA 03/2022 - 01/2013
2	Methacholine Chloride (Methacholine)FDA Link 12/2020 - 02/2015
2	LigandsIBA 01/2019 - 01/2018
2	InterleukinsIBA 10/2017 - 08/2017
2	imperatorinIBA 10/2017 - 01/2016
2	AclarubicinIBA 01/2017 - 01/2013
2	zerumboneIBA 01/2017 - 02/2015
2	ferulic acid (sodium ferulate)IBA 01/2017 - 01/2015
2	Immunoglobulin G (IgG)IBA 02/2015 - 01/2013
1	Oxygen (Dioxygen)IBA 10/2022
1	Glucose (Dextrose)FDA LinkGeneric 06/2022
1	Deoxyglucose (2 Deoxy D glucose)IBA 06/2022
1	Antipsychotic Agents (Antipsychotics)IBA 06/2022
1	Adenosine Triphosphate (ATP)IBA 06/2022
1	Penfluridol (Semap)IBA 06/2022
1	Sirtuin 1IBA 06/2022
1	acteosideIBA 05/2022
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 05/2022
1	schizandrin BIBA 03/2022
1	Heme Oxygenase-1IBA 03/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	SootIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	catalpolIBA 07/2021
1	OzoneIBA 01/2021
1	Nitrogen DioxideIBA 01/2021
1	CollagenIBA 12/2020
1	Drinking WaterIBA 02/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 12/2017
1	VenomsIBA 10/2017
1	SteroidsIBA 10/2017
1	Proteins (Proteins, Gene)FDA Link 10/2017
1	DiterpenesIBA 10/2017
1	Interleukin-33IBA 10/2017
1	ovatodiolideIBA 10/2017
1	osthol (osthole)IBA 08/2017
1	bcr-abl Fusion ProteinsIBA 01/2017
1	(1- methyl- 1H- indol- 5- yl)- (3,4,5- trimethoxy- phenyl)- methanoneIBA 01/2017
1	Mebendazole (Anti-Worm)FDA Link 09/2016
1	Tubulin ModulatorsIBA 05/2016
1	Propidium (Propidium Iodide)IBA 05/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2016
1	Annexin A5IBA 05/2016
1	Oncogene Proteins (Oncogene Protein)IBA 01/2016
1	AntibodiesIBA 02/2015
1	HMGB1 Protein (HMG1)IBA 01/2015
1	InterferonsIBA 01/2013
1	LatexIBA 07/2012
1	LithiumIBA 02/2011
1	N-methylisoindigotinIBA 05/2010
1	Indigo Carmine (Indigo Blue)IBA 05/2010

Therapy/Procedure

5	Oral Administration 05/2022 - 02/2015
2	Therapeutics 10/2017 - 01/2013
1	Immunotherapy 01/2019